A single line often inverts meaning once you see what it
answers, so neighbouring messages are always shown.
-
What's he gone and done now?
-
Just another talk to scare the shit out of people. I do it pretty well these days (scare the shit out of people - not the talk part). To be aired in 2022.
-
It was actually really interesting watching the Novavax chat yesterday: basically a 50/50 split on those who thought the results were good/bad.
-
So I agree that B117 will come to dominate quickly. BUT what if B.1.351 comes into play? Will both circulate, will one replace the other? I'm kinda "rooting" for B117.
-
2021-01-29 12:45
Edward C. Holmes
Yes, a replicatory advantage of B.1.1.7 over B.1.351 would be bloody useful!
-
The Novavax is a fucking wakeup call like no other - the lack of urgency is disturbing. I don't think most people understand exactly how problematic that is - including vaccine makers and immunologists. "We want perfect data first!". Nope. Fucking move!
-
I'm pretty certain B117 will win out first, but as immunity builds up, probably some of these other lineages - OR B117will simply pick up those mutations and continue to dominate. Will be very interesting to watch (and, of course,linages X, Y, Z coming down the pipe....)
-
Definitely more lineages coming to a place near you soon. It was striking that people just seemed to want to hear the'89%' good news from the Novavax UK trial and not think about the SA data.
-
Yes indeed Eddie - it's distressing. J and J efficacy starting off lower than Novavax.